Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2025-02-06 Sale |
2025-02-06 3:56 pm |
Revance Therapeutics Inc. | RVNC | Ware Olivia C Director |
15,000 | $0 | $0 | 0 (Direct) |
View |
2024-04-16 Sale |
2024-04-18 4:01 pm |
Arcellx Inc. | ACLX | Ware Olivia C Director |
9,402 | $55.55 | $522,260 | 36,806 (Direct) |
View |
2024-03-15 Sale |
2024-03-18 6:38 pm |
Arcellx Inc. | ACLX | Ware Olivia C Director |
9,000 | $70.4 | $633,582 | 46,208 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-02-04 Equity Swap |
2025-02-06 3:56 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Ware Olivia C Director |
16,675 | $3.65 | 0 (Direct) |
View |
2024-05-28 Option Award |
2024-06-06 4:18 pm |
N/A 2034-05-28 |
Arcellx Inc. | ACLX | Ware Olivia C Director |
8,011 | $0 | 8,011 (Direct) |
View |
2024-05-24 Option Award |
2024-05-29 5:55 pm |
N/A 2034-05-23 |
Contineum Therapeutics Inc. | CTNM | Ware Olivia C Director |
3,700 | $0 | 3,700 (Direct) |
View |
2024-05-01 Option Award |
2024-05-03 08:47 am |
N/A 2034-04-30 |
Revance Therapeutics Inc. | RVNC | Ware Olivia C Director |
38,458 | $0 | 55,133 (Direct) |
View |
2024-04-16 Exercise |
2024-04-18 4:01 pm |
N/A N/A |
Arcellx Inc. | ACLX | Ware Olivia C Director |
9,402 | $7.61 | 36,806 (Direct) |
View |
2024-04-16 Exercise |
2024-04-18 4:01 pm |
N/A 2032-05-16 |
Arcellx Inc. | ACLX | Ware Olivia C Director |
9,402 | $0 | 36,806 (Direct) |
View |
Ownership |
2024-04-04 5:59 pm |
N/A 2034-03-26 |
Contineum Therapeutics Inc. | CTNM | Ware Olivia C Director |
0 | $0 | 29,479 (Direct) |
View |
2024-03-15 Exercise |
2024-03-18 6:38 pm |
N/A N/A |
Arcellx Inc. | ACLX | Ware Olivia C Director |
9,000 | $7.61 | 46,208 (Direct) |
View |
2024-03-15 Exercise |
2024-03-18 6:38 pm |
N/A 2032-05-16 |
Arcellx Inc. | ACLX | Ware Olivia C Director |
9,000 | $0 | 46,208 (Direct) |
View |
2023-06-14 Option Award |
2023-06-16 4:23 pm |
N/A 2033-06-14 |
Arcellx Inc. | ACLX | Ware Olivia C Director |
11,459 | $0 | 11,459 (Direct) |
View |
2023-05-03 Option Award |
2023-05-05 5:15 pm |
N/A 2033-05-02 |
Revance Therapeutics Inc. | RVNC | Ware Olivia C Director |
9,449 | $0 | 22,590 (Direct) |
View |
2022-05-16 Option Award |
2022-05-17 5:14 pm |
N/A 2032-05-16 |
Arcellx Inc. | ACLX | Ware Olivia C Director |
55,208 | $0 | 55,208 (Direct) |
View |
2022-05-04 Option Award(A) |
2022-05-13 6:16 pm |
N/A 2032-05-03 |
Revance Therapeutics Inc. | RVNC | Ware Olivia C Director |
10,756 | $0 | 10,756 (Direct) |
View |
2022-05-04 Option Award |
2022-05-06 6:17 pm |
N/A 2032-05-03 |
Revance Therapeutics Inc. | RVNC | Ware Olivia C Director |
17,402 | $0 | 24,484 (Direct) |
View |
2021-05-05 Option Award |
2021-05-07 7:23 pm |
N/A 2031-05-04 |
Revance Therapeutics Inc. | RVNC | Ware Olivia C Director |
1,942 | $0 | 8,350 (Direct) |
View |
2021-03-08 Option Award |
2021-03-10 7:13 pm |
N/A 2031-03-07 |
Revance Therapeutics Inc. | RVNC | Ware Olivia C Director |
17,569 | $0 | 17,569 (Direct) |
View |